One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Several individuals enrolled in a phase 3 trial for Eli Lilly's (NYSE:LLY) next-generation obesity drug, retatrutide, say ...
Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...
Scientists have found specialized neurons in the brains of mice that order the animals to stop eating. Though many feeding ...
Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...
Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...
As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial ...
In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...
For Kristian Cook, every pizza box he opened was another door closed on the path to overcoming obesity. “I had massive ...
Love Island star Shaughna Phillips has spoken about her experience with the condition that can leave sufferers ashamed and ...